Behboudi-Gandevani Samira, Bidhendi-Yarandi Razieh, Panahi Mohammad Hossein, Vaismoradi Mojtaba
Faculty of Nursing and Health Sciences, Nord University, Bodø, Norway.
Department of Biostatistics, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Front Oncol. 2021 Oct 14;11:696702. doi: 10.3389/fonc.2021.696702. eCollection 2021.
The primary objective of this systemic review and meta-analysis was to investigate the risk of developing composite outcome of all cancers, regardless of the type of cancer among men with infertility diagnosis compared to fertile counterparts. The secondary objective was to compare the pooled risk of developing individual specific cancers between two groups.
A systematic literature search was performed on the databases of PubMed (including Medline), Scopus, and Web of Science to retrieve observational studies published in English language from 01.01.1990 to 28. 02. 2021. They assessed cancer events in males with an infertility diagnosis compared to controls without infertility. The outcomes of interest were a composite outcome of cancers including all known cancer types, and also specific individual cancers. The fixed/random effects model was used to analyze heterogeneous and non-heterogeneous results. Publication bias was assessed using the Harbord test, Egger test, Begg test, and funnel plot. The pooled odds ratio of cancers was calculated using the DerSimonian and Laird, and inverse variance methods. Studies' quality and risk of bias were assessed using structured standard tools.
We included eight cohort studies involving 168,327 men with the diagnosis of infertility and 2,252,806 men without it. The total number of composite outcome of cancers as well as individual cancers including prostate, testicular and melanoma were 1551, 324, 183 and 121 in the infertile men and 12164, 3875, 849, and 450 in the fertile men, respectively. The pooled OR of the composite outcome of cancers, regardless of the type of cancer, in men with infertility was 1.4 folds higher than those without infertility (pooled OR = 1.43, 95% confidence interval [CI]: 1.25-1.64). Meta-analysis of individual cancers including prostate, testicular and melanoma between two groups was carried out. The pooled ORs of testicular and prostate cancers in men with the diagnosis of infertility were significantly higher than controls without infertility (pooled OR = 1.91, 95% CI: 1.52-2.42 and pooled OR = 1.48, 95% CI: 1.05-2.08, respectively). Additionally, the pooled OR of melanoma in men with infertility was 1.3 folds higher than those without infertility (pooled OR = 1.31, 95% CI: 1.06-1.62).
A greater risk of cancers in men with male infertility was found suggesting that the history of male infertility might be an important risk factor for developing cancers in later life. Further well-designed long-term population-based prospective studies, considering all known cancers and their accompanying risk factors should be conducted to support our findings.
本系统评价和荟萃分析的主要目的是调查与可育男性相比,诊断为不育的男性发生所有癌症(无论癌症类型)的综合结局的风险。次要目的是比较两组之间发生特定个体癌症的合并风险。
在PubMed(包括Medline)、Scopus和Web of Science数据库中进行系统的文献检索,以检索1990年1月1日至2021年2月28日以英文发表的观察性研究。这些研究评估了诊断为不育的男性与未患不育症的对照相比的癌症事件。感兴趣的结局是包括所有已知癌症类型的癌症综合结局,以及特定的个体癌症。采用固定/随机效应模型分析异质性和非异质性结果。使用Harbord检验、Egger检验、Begg检验和漏斗图评估发表偏倚。使用DerSimonian和Laird法以及逆方差法计算癌症的合并比值比。使用结构化标准工具评估研究质量和偏倚风险。
我们纳入了八项队列研究,涉及168327名诊断为不育的男性和2252806名未患不育症的男性。不育男性中癌症综合结局以及包括前列腺癌、睾丸癌和黑色素瘤在内的个体癌症的总数分别为1551例、324例、183例和121例,可育男性中分别为12164例、3875例、849例和450例。无论癌症类型如何,不育男性发生癌症综合结局的合并比值比是未患不育症男性的1.4倍(合并比值比=1.43,95%置信区间[CI]:1.25-1.64)。对两组之间包括前列腺癌、睾丸癌和黑色素瘤在内的个体癌症进行了荟萃分析。诊断为不育的男性中睾丸癌和前列腺癌的合并比值比显著高于未患不育症的对照(合并比值比分别为1.91,95%CI:1.52-2.42和合并比值比=1.48,95%CI:1.05-2.08)。此外,不育男性中黑色素瘤的合并比值比是未患不育症男性的1.3倍(合并比值比=1.31,95%CI:1.06-1.62)。
发现男性不育患者患癌症的风险更高,这表明男性不育史可能是晚年患癌症的一个重要风险因素。应进行进一步设计良好的基于人群的长期前瞻性研究,考虑所有已知癌症及其伴随的风险因素,以支持我们的研究结果。